Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ONCS OncoSec Medical > Detailed Quotes

ONCS OncoSec Medical

Watchlist
2.100
-0.100-4.55%
Trading Session  02/01 13:51 ET
High
2.163
Open
2.160
Turnover
97.98K
Low
2.030
Pre Close
2.200
Volume
47.60K
Market Cap
6.24M
P/E(TTM)
Loss
52wk High
31.900
Shares
2.97M
P/E(Static)
Loss
52wk Low
1.500
Float Cap
4.31M
Bid/Ask %
80.00%
Historical High
8755.996
Shs Float
2.05M
Volume Ratio
1.05
Historical Low
1.500
Dividend TTM
--
Div Yield TTM
--
P/B
-6.34
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
2.32%
Amplitude
6.03%
Avg Price
2.058
Lot Size
1
Float Cap
4.31M
Bid/Ask %
80.00%
Historical High
8755.996
Shs Float
2.05M
Volume Ratio
1.05
Historical Low
1.500
Dividend TTM
--
P/B
-6.34
Dividend LFY
--
Turnover Ratio
2.32%
Amplitude
6.03%
Avg Price
2.058
Lot Size
1
Price Forecast

News

Comment

Company Overview More
OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered in Pennington, NJ.
CEO: Mr. Robert H. Arch
Market: NASDAQ
Listing Date: 05/29/2015
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist